These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19806639)

  • 1. A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: a predictor of nodal metastasis location.
    Diaz LK; Gilcrease MZ
    Cancer; 2009 Dec; 115(24):5845; author reply 5846. PubMed ID: 19806639
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of sentinel lymph nodes in breast cancer.
    Cserni G
    Histopathology; 2005 Jun; 46(6):697-702. PubMed ID: 15910602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: a predictor of nodal metastasis location.
    Bleicher RJ; O'Sullivan MJ; Ciocca V; Ciocca RM; Perkins LA; Ross E; Li T; Patchefsky AS; Sigurdson ER; Joseph NE; Sesa L; Morrow M
    Cancer; 2008 Dec; 113(11):3100-7. PubMed ID: 18973177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
    Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
    Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blue-dye technique complements four-node sampling for early breast cancer.
    Ishikawa T; Momiyama N; Hamaguchi Y; Tanabe M; Tomita S; Ichikawa Y; Nakatani Y; Sasaki T; Nozawa A; Inayama Y; Inui K; Shimada H
    Eur J Surg Oncol; 2005 Dec; 31(10):1119-24. PubMed ID: 16005597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer.
    Krauth JS; Charitansky H; Isaac S; Bobin JY
    Eur J Surg Oncol; 2006 May; 32(4):400-4. PubMed ID: 16504456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients.
    Bertoglio S; Sandrucci S; Percivale P; Goss M; Gipponi M; Moresco L; Mussa B; Mussa A
    J Surg Oncol; 2004 Mar; 85(3):166-70. PubMed ID: 14991889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological evaluation of sentinel lymph nodes in breast cancer: a practical academic perspective from America.
    Weaver DL
    Histopathology; 2005 Jun; 46(6):702-6. PubMed ID: 15910603
    [No Abstract]   [Full Text] [Related]  

  • 9. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence (Br J Surg 2009; 96: 1289-1294).
    Chiu CC
    Br J Surg; 2010 Mar; 97(3):455; author reply 455-6. PubMed ID: 20140947
    [No Abstract]   [Full Text] [Related]  

  • 10. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
    van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramammary lymph node metastasis of breast cancer after sentinel node biopsy: two cases and a review of the literature.
    Bats AS; Coutant C; Antoine M; Uzan S; Barranger E
    Eur J Surg Oncol; 2009 Mar; 35(3):331-2. PubMed ID: 18479883
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphatic mapping and sentinel node biopsy in gastric cancer.
    Song X; Wang L; Chen W; Pan T; Zhu H; Xu J; Jin M; Finley RK; Wu J
    Am J Surg; 2004 Feb; 187(2):270-3. PubMed ID: 14769318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
    Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
    Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramammary lymph node metastasis of breast cancer after sentinel node biopsy: two cases and a review of the literature.
    Araújo C; Fougo JL
    Eur J Surg Oncol; 2009 Dec; 35(12):1354. PubMed ID: 19592195
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sentinel lymph node reevaluation].
    Siewert JR
    Chirurg; 2004 Aug; 75(8):749-50. PubMed ID: 15515215
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 18. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
    Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
    J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.